#EXIT
PANDEMIC
TET RAY
INTERNATIONAL
HEALTH REGULATIONS
3
Covid Crimes
a
Fudging
the
Stats
b
Pandemic Transmission Model - Neil Ferguson and the WHO’s Monstrous LIE
Prof Neil Ferguson
Imperial College, London
That Started it All
https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf
c
Neil Ferguson – A Monumental Fraud of Monstrous Proportions
Table: Performance of Imperial College Modelling in 4 Non-Lockdown Countries & the United States
https://www.aier.org/article/the-failure-of-imperial-college-modeling-is-far-worse-than-we-knew/
d
For 6% of the deaths, COVID-19 was the only cause mentioned
https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm?fbclid=IwAR3-wrg3tTKK5-9tOHPGAHWFVO3DfslkJ0KsDEPQpWmPbKtp6EsoVV2Qs1Q#Comorbidities
e
The Crime of the...
HEALTHY
i
The fEAR Porn. The LIES. The More LIES. THe cON
ii
Asymptomatic = Sick Syndrome
https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-how-is-it-transmitted
f
The Rap Sheet expands...
The Mask Fiasco |
Jun, 5, 2020 “The WHO has also updated their guidelines, for use of masks by the general public, ..., in light of evolvingevidence, WHO advises governments to encourage the general public to wear masks....” | January, 22, 2021 “There is no scientific medical reason for any healthy person to wear a mask outside of a hospital. If you have no respiratory symptoms, such as, fever, cough or runny nose, you do not need to wear a medicalmask.” |
g
The Banality of ...
....Not Saving Lives as Treatment
WHO has fallen victim to neoliberal globalization
Sent: Monday, January 22, 2007 4:29 PM Subject: Open letter to Dr Chan
"Academic institutions . . . have become businesses in their own right, seeking to commercialize for themselves research discoveries rather than preserve their independent scholarly status"
Alison Katz, IndependentWHO
http://www.next-up.org/pdf/AlisonKatzOpenLetterMargaretChanWHO.pdf
LancetNEJMGate: Fraudulent Study Retracted
Findings
We were unable to confirm a benefit of hydroxychloroquine or chloroquine,
when used alone or with a macrolide, on in-hospital outcomes for COVID-19. Each of these drug regimens was associated with decreased in-hospital survival and an increased frequency of ventricular arrhythmias when used for treatment of COVID-19.
The Lancet study based on data analysis of 96,032 patients hospitalized with COVID-19 between Dec 20, 2019, and April 14, 2020 from 671 hospitals Worldwide. The database was fabricated and the findings was based on completely fake figures and test trials.
The Study which killed the Hydroxychloroquine cure was essentially a colossal:
Fraud
https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)31180-6.pdf
LancetNEJMGate: Fraudulent Study Retracted
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269709/
https://www.thegatewaypundit.com/2020/06/exclusive-lancet-study-hydroxychloroquine- complete-fraud-authors-linked-pharmaceutical-industry-people-died-lies/
The Lancet Study’s entire purpose was therefore to lie about Hydroxychloroquine in order to promote more expensive pharmaceutical alternatives.
LancetNEJMWHOGate: WHO responds
WHO pauses Hydroxychloroquine Arm of Covid-19 Clinical Trial – After Lancet Study finds higher Mortality Rate among patients taking the drug
“In light of a paper published last week in the Lancet that showed people taking hydroxychloroquine were at higher risk of death and heart problems, there would be "a temporary pause" on the hydroxychloroquine arm of its global clinical trial.
Tedros Adhanom Ghebreyesus WHO Director-General
26.05.2020 https://www.newindianexpress.com/world/2020/may/25/who-study-into-experimental-covid-19-treatments-pauses-testing-on-trumps-drug-hydroxychloroquine-2147914.html
"Hydroxychloroquine does not result in the reduction of mortality of hospitalized COVID-19 patients," the WHO reported (Solidarity Trial)
Hydroxychloroquine and Role as COVID-19 prophylaxis
Is in on the Fraud |
15 October 2020
Interim results from the Solidarity Therapeutics Trial, coordinated by the World Health Organization, indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among 14 200 hospitalized patients.
Trial 14 200 hospitalized patients, 52 countries, 200 hospitals, 2000 researchers
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments https://www.who.int/news/item/15-10-2020-solidarity-therapeutics-trial-produces-conclusive-evidence-on-the-effectiveness-of-repurposed-drugs-for-covid-19-in-record-time
Drugs to prevent Covid-19 Living Guide 24th March 2023 |
Table: Characteristics and outcomes of the RCTs evaluating hydroxychloroquine
Outcome | Intervention Impact of Hydroxychloroquine |
Mortality | 3 per 1000 Little or no effect on mortality |
Admission to Hospital | 1 per 1000 Little or no effect on hospital admission |
Laboratory-confirmed SARS-CoV-2 infection | 59 per 1000 Little or no effect on preventing infection |
Adverse events leading to discontinuation | 28 per 1000 A small increase in adverse effects leading to discontinuation |
Recommendations
The panel felt that further research was unlikely to uncover a subgroup of patients that benefit from hydroxychloroquine, therefore recommends against the use of hydroxychloroquine as a prophylaxis
WHO Therapeutics Steering Committee
https://apps.who.int/iris/bitstream/handle/10665/366530/WHO-2019-nCoV-prophylaxes-2023.1-eng.pdf
And then of course there was the...
in
fiasco...
I
v
er ct m
e
trial : Dr Andrew Hill – Conflicts of Interest Consultant
$50 million
Advisor to Bill and Melinda Gates Foundation
$40 million
Centre of Excellence for Long- acting Therapeutics (CELT)
Funders
Dr. Andrew Hill
Senior Visiting Research Fellow Dept Pharmacology
Advisor
Previous employment Developer of antivirals
HIV Collaborative Fund | ||||||
PEPFAR | ||||||
Consultant
E D I T O R
trial : Dr Andrew Hill – Conflicts of Interest
During the interview, Dr Hill admits that his funder, UNITAID influenced his conclusions to the aforementioned paper.
Four days before publication, Hill’s sponsor Unitaid gave the University of Liverpool, Hill’s employer $40 million.
4th March 2022
Controversial Journal Article
Meta-analysis of randomized trials of Ivermectin to treat SARS-CoV-2 infection
Hill, A et.al. Research Square, 19 Jan 2021
Results
Ivermectin was associated with reduced inflammation, faster viral clearance. Ivermectin showed significantly shorter duration of hospitalization, and in moderate or severe infection, there was a 75% reduction in deaths, with favourable clinical recovery and reduced hospitalization.
Conclusions
Not yet a sufficiently robust evidence base to justify the use or regulatory approval of ivermectin. However...clear need for additional, higher-quality and larger-scale clinical trials, warranted to investigate the use of ivermectin further.
Funder
https://www.oraclefilms.com/alettertoandrewhill https://worldcouncilforhealth.org/multimedia/dear-andy-dr-tess-lawrie/ https://www.researchsquare.com/article/rs-148845/v1
trial : Dr Andrew Hill – Conflicts of Interest
https://www.worldtribune.com/researcher-andrew-hills-conflict-a-40-million-gates-foundation-grant-vs-a-half-million-human-lives/
: Dr Andrew Hill/Prof Andrew Owen – Conflicts of Interest
Nitazoxanide | |||
AGILE Clinical Team | |||
Funders
Scientific Advisor COVID-19 Guideline Development Group
Professor Andrew Owen
Editor of Andrew Hill paper on Ivermectin
Professor of Pharmacology & Therapeutics
£2.2 million
Scientific Advisor
Principal Investigator
£3million
Funding Partners
Co-Director Centre of Excellence in Long-acting Therapeutics (CELT)
Remdesivir
Solid Drug Nanoparticle technology
VIR-7831 and VIR-7832, novel therapies COVID owned by
Lead Molnupiravir Trial
Consultant
Director & CSO & shareholder
: Dr Andrew Hill/Prof Andrew Owen – Conflicts of Interest
https://rairfoundation.com/deadly-cover-up-who-buried-the-research-proving-ivermectin-saves-covid-patients-lives/
World Crime Organization....Not Saving Lives as Treatment
https://www.who.int/news-room/feature-stories/detail/who-advises-that-ivermectin-only-be-used-to-treat-covid-19-within-clinical-trials
May, 2021
bans IVERMECTIN |
https://www.sahpra.org.za/wp-content/uploads/2020/12/22-December-2020-Ivermectin.pdf
Ivermectin for COVID-19: real-time meta analysis of 99 studies
Relative Risk
Analysis
Oct 2023
Primary Outcome 52% 99 Ventilation 29% 18 Hospitalisation 34% 29 Cases 81% 16 RCTs 55% 46 Prophylaxis 85% 17 Late Treatment 41% 45
137,686 33,157 44,784 13,696 11,855 19,764 59,776
c19ivm.org
https://c19ivm.org/meta.html
Improv -ement
No. No. Studies Patients
All Studies 62%
99 137,255
Statistically significant lower risk is seen for mortality, ventilation, ICU admission, hospitalization, recovery, cases, and viral clearance. 60 studies from 54 independent teams in 24 different countries show statistically significant improvements.
Meta analysis using the most serious outcome shows 62% [51-70%] and 85% [77-90%] lower risk for early treatment and prophylaxis, with similar results for higher quality studies, primary outcomes, peer- reviewed studies, and for RCTs.
Results are very robust — in worst case exclusion sensitivity analysis 62 of 99 studies must be excluded to avoid finding statistically significant efficacy.
Pharmacokinetics show significant inter-individual variability Guzzo. Efficacy may vary depending on the manufacturer Williams.
Over 20 countries adopted ivermectin for COVID-19. The evidence base is much larger and has much lower conflict of interest than typically used to approve drugs.
Mortality 49%
ICU Admission 38%
51 122,827
13 24,089
Recovery 43%
Peer-reviewed 61%
35 7,837
Viral Clearance 42%
30 4,157
83 125,940
Early Treatment 62%
37 57,715
------- after exclusions
0 0.5 1.0 1.5+ Favors Favors Ivermectin Control
https://c19ivermectin.com/isummary.png
Ivermectin for COVID-19: real-time meta analysis of 99 studies
https://c19ivm.org/meta.html
LOC
h
KDOWN CRIMES
May, 16, 2021
https://www.realclearmarkets.com/articles/2021/05/14/the_world_health_organization_endorses_lockdowns_forever_777027.html
The following graph was produced by UK Column and demonstrates the lack of correlation between lockdown and "saving lives"
https://www.ukcolumn.org/article/who-controls-british-government-response-covid19-part-one
Measures
Isolation
Quarantine of exposed individuals
Entry and exit screening
Border closures
Contact tracing
Internal travel restrictions
Workplace measures and closures
2019 Non-Pharmaceutical Interventions (NPI) for pandemic countermeasures
Guidelines and Actions
Voluntary isolation at home of sick individuals
Home quarantine of exposed individuals to reduce transmission is not recommended because there is no obvious rationale for this measure
Entry and exit screening for infection in travellers is not recommended, because of the lack of sensitivity of these
Measures. Nor recommended
Border closure is generally not recommended
Not recommended in general because there is no obvious rationale for it
Evidence
Very low
Very low (lack of effectiveness in reducing influenza transmission)
Very low
Very low (unknown)
Recommendations
At all times
2019
Very low (variable effectiveness)
Not recommended in any circumstances
In 2019
Conditionally recommended
Very low
Very low
Only under extraordinary circumstances
School measures and closures
Avoiding crowding
Face masks
Teleworking from home, staggering shifts
Increasing desk spacing, reducing mixing between classes
Increase the distance and reduce the density among populations
No evidence that this is effective in reducing transmission
Very low (variable effectiveness)
Very low (unknown)
Moderate
https://apps.who.int/iris/bitstream/handle/10665/329438/9789241516839-eng.pdf?ua=1
We shall never forget!!!
We shall never forget!!!
We shall never forget!!!
We shall never forget!!!
We shall never forget!!!
We shall never forget!!!
We shall never forget!!!
“...now we have to go back into families find those people who are sick and remove them and isolate them...”
Dr Michael J. Ryan
Executive Director of the World Health Organization's Health Emergencies Programme
Then there are the ...
VACCINES
i
The Perpetual LIE |
No one is safe, until everyone is safe
COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator
Total Value Commitment | |
Access to COVID-19 Tools (ACT) Accelerator | $226 million |
GAVI COVAX AMC $156 million World Health Organisation $751 million
Coalition for Epidemic Preparedness Innovations CEPI) | $275 million |
UNICEF | $150 million |
Gates Foundation funding/investment in Covid Vaccine Candidates: Conflicts of Interest
Company | Covid Vaccine Candidate | Type | Value Investment (US$) |
Pfizer/BioNTech | BNT162b2 mRNA | To develop mRNA-based vaccines for infectious diseases | $27,500,000 (July 2022) $100,000,000 (May 2022) $4,918,943 (BioNTech 2020) $17,252,854 (2016) |
AstraZeneca | ChAdOx1 nCov-19 | Develop COVID-19 DNA vaccine | $750 million (2020)(20) |
ModernaTX, Inc. | mRNA-1273 | To develop mRNA-based vaccines for infectious diseases | $100 million (future projects upto 2022) $1,051,128 (2019) |
Novavax | NVX-CoV2373 | Purified protein antigen Vaccine development | $15 million (2020) |
CureVac | CVnCoV | mRNA coronavirus vaccine | $52 million (27) |
Icosavax Inc. | IVX-411 | Develop COVID-19 vaccine | $10 million (2020) |
Inovio Pharmaceuticals | INO-4800 | Develop COVID-19 DNA vaccine | $5 million (2020) |
Vir Biotechnology, Inc. | HIV vaccine development | $10,000,000 (2022) $10,034,896 (2021) | |
Merck | Molnupiravir | Antiviral drug | $120 million (2021) |
Total Contributions (2020-2021)
Country/ Foundation | Total Contribution | Percentage |
Germany | $1268 million | 21.7% |
Gates Foundation/ Gavi | $1183 million | 20.3% |
USA | $693 million | 11.9% |
Total | $5840.4 million |
https://www.who.int/about/funding/contributors
WHO: Influence of the Gates Foundation
10
j
Adverse Events...
...Following Immunization
(AEFI)
WHO & Pfizer Crimes & Corruption
https://www.who.int/news-room/feature-stories/detail/side-effects-of-covid-19-vaccines
WHO & Pfizer Crimes & Corruption |
BNT162b2 REF: FDA-CBER-2021-5683-0000054 |
APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST 9 pages of AEFI’s (Total 139 888) unreported by Pfizer and WHO |
https://archive.org/details/cumulative-analysis-of-post-authorization-adverse-event-reports-of-pf-07302048-bnt162b2
WHO & Pfizer Crimes & Corruption |
BNT162b2 REF: FDA-CBER-2021-5683-0000054 |
Adverse Events Following Immunization (AEFI’s) reported The System Organ Classes (SOCs) that contained the greatest number (≥2%) of events, in the overall dataset, were General disorders and administration site conditions (51,335 AEs), Nervous system disorders (25,957), Musculoskeletal and connective tissue disorders (17,283), Gastrointestinal disorders (14,096), Skin and subcutaneous tissue disorders (8,476), Respiratory (Covid-19 - 1927, 4.6%), thoracic and mediastinal disorders (8,848), Infections and infestations (4,610), Injury, poisoning and procedural complications (5,590), and Investigations (3,693) Limited Listed AEFI’s Suddenunexplained death in epilepsy Myocarditis post infection Myocardial infarction Pericarditis Pericarditis lupus Guillain-Barre syndrome COVID-19 pneumonia Total: 139 888 AEFI’s |
https://archive.org/details/cumulative-analysis-of-post-authorization-adverse-event-reports-of-pf-07302048-bnt162b2
Pfizer & WHO Crimes & Corruption | ||||||||||||||
BNT162b2 REF: FDA-CBER-2021-5683-0000054 | ||||||||||||||
| ||||||||||||||
https://archive.org/details/cumulative-analysis-of-post-authorization-adverse-event-reports-of-pf-07302048-bnt162b2
New Pfizer data dump. Read it for yourself. 1 child was born alive out of 270. 238 out due to "reasons unknown" Safe and effective.
The WHO – Covid Vaccine Adverse Event
https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/pt/covidwho-2138820?lang=en
No comments:
Post a Comment